Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.
COVID-19
Multiple sclerosis
SARS-CoV-2
Vaccines
Journal
Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
23
03
2021
accepted:
24
04
2021
pubmed:
3
6
2021
medline:
20
7
2021
entrez:
2
6
2021
Statut:
ppublish
Résumé
People with multiple sclerosis (MS) are at risk for infections that can result in amplification of baseline symptoms and possibly trigger clinical relapses. Vaccination can prevent infection through the activation of humoral and cellular immune responses. This is particularly pertinent in the era of emerging novel vaccines against severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019 (COVID-19). MS disease-modifying therapies (DMTs), which affect the immune system, may impact immune responses to COVID-19 vaccines in people with MS. The objective of this article is to provide information on immune system responses to vaccinations and review previous studies of vaccine responses in people with MS to support the safety and importance of receiving currently available and emerging COVID-19 vaccines. Immunological studies have shown that coordinated interactions between T and B lymphocytes of the adaptive immune system are key to successful generation of immunological memory and production of neutralizing antibodies following recognition of vaccine antigens by innate immune cells. CD4
Identifiants
pubmed: 34075554
doi: 10.1007/s12325-021-01761-3
pii: 10.1007/s12325-021-01761-3
pmc: PMC8169434
doi:
Substances chimiques
COVID-19 Vaccines
0
Glatiramer Acetate
5M691HL4BO
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Pagination
3550-3588Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. The Author(s).
Références
Neurology. 2015 Mar 3;84(9):872-9
pubmed: 25636714
Curr Neurol Neurosci Rep. 2017 Sep 22;17(11):88
pubmed: 28940162
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Cancer Gene Ther. 2021 Feb;28(1-2):5-17
pubmed: 32457487
J Neurol. 2020 Dec;267(12):3467-3475
pubmed: 32638107
Neurol Neuroimmunol Neuroinflamm. 2020 Jan 9;7(2):
pubmed: 31919278
Am J Transplant. 2020 Sep;20(9):2551-2558
pubmed: 32185859
Mucosal Immunol. 2018 Nov;11(6):1743-1752
pubmed: 30115996
Neurology. 2013 Sep 3;81(10):872-6
pubmed: 23925762
Acta Otorhinolaryngol Ital. 2010 Aug;30(4):198
pubmed: 21253285
Oncotarget. 2016 Sep 27;7(39):62898-62911
pubmed: 27588486
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Immunity. 2010 Oct 29;33(4):516-29
pubmed: 21029962
Front Immunol. 2018 Aug 27;9:1941
pubmed: 30210496
JAMA Neurol. 2021 Jun 1;78(6):699-708
pubmed: 33739362
Eur J Neurol. 2002 Jan;9(1):63-7
pubmed: 11784378
Clin Neuropharmacol. 2010 Mar-Apr;33(2):91-101
pubmed: 20061941
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S24-32
pubmed: 19932920
Arthritis Care Res (Hoboken). 2014 Jul;66(7):1016-26
pubmed: 24339395
Immunology. 2012 Jan;135(1):19-26
pubmed: 22044118
PLoS One. 2011 Apr 29;6(4):e19346
pubmed: 21559409
Clin Microbiol Rev. 2019 Mar 13;32(2):
pubmed: 30867162
J Clin Cell Immunol. 2013 Jul 8;4(4):
pubmed: 24363961
Semin Immunol. 2013 Apr;25(2):152-9
pubmed: 23735226
Nature. 2020 Oct;586(7830):567-571
pubmed: 32756549
Methods Mol Biol. 2018;1781:327-340
pubmed: 29705855
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Neurol Neuroimmunol Neuroinflamm. 2021 Jan 27;8(2):
pubmed: 33504634
Lancet. 2018 Apr 21;391(10130):1622-1636
pubmed: 29576504
Nat Rev Immunol. 2013 Jun;13(6):412-26
pubmed: 23681096
Arthritis Rheum. 2011 Jun;63(6):1486-96
pubmed: 21384334
PLoS One. 2013 Nov 05;8(11):e78532
pubmed: 24223820
Vaccines (Basel). 2020 Jun 16;8(2):
pubmed: 32560088
PLoS One. 2014 Nov 20;9(11):e113025
pubmed: 25411844
J Immunol. 2002 Jul 1;169(1):375-83
pubmed: 12077267
Vet Res. 2017 Sep 22;48(1):57
pubmed: 28938920
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
Mult Scler Relat Disord. 2020 Oct;45:102420
pubmed: 32736217
Sci Immunol. 2017 Aug 4;2(14):
pubmed: 28778905
Vaccine. 2013 Sep 13;31(40):4389-97
pubmed: 23856331
Curr Med Res Opin. 2014 Feb;30(2):251-62
pubmed: 24131282
Mult Scler Relat Disord. 2020 Jun;41:101982
pubmed: 32070858
J Clin Pharmacol. 2012 Dec;52(12):1879-90
pubmed: 22174429
Front Immunol. 2015 Oct 19;6:520
pubmed: 26539193
J Neurol Sci. 2007 May 15;256 Suppl 1:S5-13
pubmed: 17346747
Lancet. 2008 Oct 25;372(9648):1502-17
pubmed: 18970977
Clin Vaccine Immunol. 2016 Jan 27;23(3):236-42
pubmed: 26818953
Drugs. 2014 Apr;74(6):659-74
pubmed: 24740824
Mult Scler. 2021 Mar;27(3):347-359
pubmed: 32940128
Mult Scler. 2011 Jun;17(6):672-80
pubmed: 21212088
Eur J Neurol. 2021 Oct;28(10):3384-3395
pubmed: 33340215
Front Cell Infect Microbiol. 2021 Feb 26;11:624483
pubmed: 33718270
Neurology. 2015 Jan 6;84(1):99-100
pubmed: 25416038
Clin Exp Immunol. 2017 May;188(2):183-194
pubmed: 28249350
J Immunol. 2009 Feb 15;182(4):1868-76
pubmed: 19201839
Mult Scler Relat Disord. 2013 Oct;2(4):391-4
pubmed: 25877852
Vaccine. 2018 Sep 18;36(39):5832-5845
pubmed: 30122649
Sci Transl Med. 2013 Sep 25;5(204):204ra130
pubmed: 24068737
Mult Scler Relat Disord. 2019 Jun;31:173-188
pubmed: 31159998
Clin Dev Immunol. 2012;2012:925135
pubmed: 22474485
Eur J Immunol. 2010 Sep;40(9):2482-92
pubmed: 20602436
Front Pharmacol. 2020 Jun 19;11:937
pubmed: 32636754
J Virol. 2014 Oct;88(19):11034-44
pubmed: 25056892
Open Forum Infect Dis. 2018 Jul 16;5(8):ofy174
pubmed: 30094293
Autoimmun Rev. 2012 Jan;11(3):212-8
pubmed: 21621004
Cold Spring Harb Perspect Med. 2019 Feb 1;9(2):
pubmed: 29440323
J Glob Infect Dis. 2011 Jan;3(1):73-8
pubmed: 21572612
J Clin Med. 2020 Dec 16;9(12):
pubmed: 33339436
CNS Drugs. 2021 Mar;35(3):317-330
pubmed: 33743151
Neurol Neuroimmunol Neuroinflamm. 2017 Sep 13;4(6):e398
pubmed: 28955715
J Neurol Neurosurg Psychiatry. 2020 Aug 27;:
pubmed: 32855290
J Neurol Sci. 2014 Jun 15;341(1-2):22-7
pubmed: 24731783
JAMA Neurol. 2016 Feb;73(2):219-25
pubmed: 26720195
Neurology. 2013 Aug 6;81(6):552-8
pubmed: 23851964
Int J MS Care. 2015 Sep-Oct;17(5):221-30
pubmed: 26472943
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Front Immunol. 2020 Oct 14;11:583019
pubmed: 33178213
Clin Immunol. 2021 Feb;223:108554
pubmed: 32777270
Mult Scler. 2016 Jul;22(8):1061-1070
pubmed: 26459150
Virology. 2006 Jan 5;344(1):230-9
pubmed: 16364753
N Engl J Med. 2020 Dec 10;383(24):2320-2332
pubmed: 32877576
J Virol. 2007 Dec;81(23):12720-9
pubmed: 17804500
Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(2):e70
pubmed: 25738167
Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):49
pubmed: 30263032
Acta Neurol Scand. 2018 Oct;138(4):327-331
pubmed: 29797711
PLoS One. 2020 Oct 30;15(10):e0240305
pubmed: 33126239
Mult Scler Relat Disord. 2021 Apr;49:102788
pubmed: 33508570
Neurol Neuroimmunol Neuroinflamm. 2017 Nov 15;5(1):e409
pubmed: 29159204
Mult Scler. 2014 Jul;20(8):1074-80
pubmed: 24436455
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S33-40
pubmed: 20061006
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Nat Immunol. 2011 Jun;12(6):509-17
pubmed: 21739679
Arch Neurol. 2008 Nov;65(11):1434-9
pubmed: 19001161
NPJ Vaccines. 2020 Sep 28;5:91
pubmed: 33083026
Mult Scler. 2020 Dec;26(14):1816-1821
pubmed: 33174475
Neurology. 2005 Dec 27;65(12):1964-6
pubmed: 16380621
Clin Immunol. 2008 Oct;129(1):80-9
pubmed: 18653385
Neurol Neuroimmunol Neuroinflamm. 2014 Sep 11;1(3):e28
pubmed: 25340080
Neurol Res. 2012 Sep;34(7):730-3
pubmed: 22709910
Immunity. 2010 Oct 29;33(4):492-503
pubmed: 21029960
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
Science. 2002 Apr 12;296(5566):346-9
pubmed: 11923495
CNS Neurosci Ther. 2019 Feb;25(2):245-254
pubmed: 30044050
Clin Neurol Neurosurg. 2010 Sep;112(7):583-91
pubmed: 20627553
Neurology. 2020 Oct 6;95(14):e1999-e2008
pubmed: 32727835
Virology. 1995 Jul 10;210(2):508-11
pubmed: 7618288
Ann Neurol. 2021 Apr;89(4):780-789
pubmed: 33480077
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
Neurology. 2019 Sep 24;93(13):584-594
pubmed: 31462584
Neurology. 2001 Apr 10;56(7):938-43
pubmed: 11294933
Front Immunol. 2020 Jun 18;11:1459
pubmed: 32655578
Int J Pharm. 2019 Dec 15;572:118813
pubmed: 31678521
Ther Clin Risk Manag. 2007 Jun;3(2):259-68
pubmed: 18360634
Mult Scler. 2020 Feb;26(2):137-152
pubmed: 31237800
Immunity. 2020 Jun 16;52(6):971-977.e3
pubmed: 32413330
J Biol Chem. 2019 Feb 1;294(5):1710-1720
pubmed: 30710018
Mult Scler. 2021 May;27(6):883-894
pubmed: 32716690
Cell Host Microbe. 2020 Jun 10;27(6):879-882.e2
pubmed: 32359396
Mult Scler Relat Disord. 2021 Feb;48:102698
pubmed: 33385826
Ann Neurol. 2011 Feb;69(2):408-13
pubmed: 21387383
J Immunol. 2008 Jun 1;180(11):7158-66
pubmed: 18490714
Eur J Neurol. 2018 Mar;25(3):527-534
pubmed: 29205701
Neurology. 2016 Nov 15;87(20):2074-2081
pubmed: 27760868
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Nat Commun. 2021 Jan 14;12(1):372
pubmed: 33446655
Brain. 2002 May;125(Pt 5):952-60
pubmed: 11960885
Mult Scler Relat Disord. 2020 May;40:101963
pubmed: 31986424